• English
    • svenska
  • svenska 
    • English
    • svenska
  • Logga in
Redigera dokument 
  •   Startsida
  • Sahlgrenska Academy / Sahlgrenska akademin
  • Institute of Medicine / Institutionen för medicin
  • Occupational and Environmental Medicine / Arbets- och miljömedicin
  • Arbete och Hälsa
  • Redigera dokument
  •   Startsida
  • Sahlgrenska Academy / Sahlgrenska akademin
  • Institute of Medicine / Institutionen för medicin
  • Occupational and Environmental Medicine / Arbets- och miljömedicin
  • Arbete och Hälsa
  • Redigera dokument
JavaScript is disabled for your browser. Some features of this site may not work without it.

147. Carbon monoxide

Sammanfattning
Carbon monoxide (CO) is an odourless and colourless gas produced by incomplete burning of carbon-based fuels. CO is also a constituent of tobacco smoke. Exposure to CO is common in many occupational areas, including those associated with vehicle exhaust. CO is an important industrial gas used in the production of chemical intermediates. CO is formed endogenously and acts as a signalling substance in the neuronal system. The main mechanism behind CO-induced toxicity is the binding of CO to haemoglobin in the blood, resulting in carboxyhaemoglobin (COHb) formation, reduced oxygen transport capacity of the blood and hypoxia. The relation between CO in air and COHb is well known and can be calculated using the Coburn-Forster-Kane (CFK) equation. Endogenous CO formation leads to a background COHb of 0.4– 0.7%. Non-smokers typically have COHb levels up to 2% whereas smokers may have COHb levels up to 10% immediately after smoking. The effects seen in acute CO poisoning cover a wide range, from mild symptoms, like shortness of breath during exercise or occasional headache at COHb 20%, to more severe ones like headache, dizziness, disturbed judgement, dimness of vision, confusion, unconsciousness, intermittent convulsion and respiratory failure at COHb above 30%. COHb levels of 50–60% are often lethal. Even COHb levels of 20% may be lethal for patients with coronary artery disease. The foetus is at higher risk than the healthy adult because of higher CO haemoglobin affinity. From controlled human and animal exposure studies the adverse effects of concern are impaired exercise performance, i.e. decreased maximal aerobic capacity in healthy volunteers (lowest observed adverse effect level (LOAEL) COHb 4.3%), increased myocardial ischaemia in patients with coronary artery disease (LOAEL COHb 2.4%), and persistent changes in the developing auditory system of the rat (LOAEL 12 ppm, corresponding to COHb 1.8% and 2.0% assuming 8 hours constant exposure at rest and heavy work, respectively). It was not possible to identify any no observed adverse effect levels (NOAELs) in these studies. No or limited data were found regarding genotoxicity, carcinogenicity, irritation and sensitisation. Combined exposure to CO and dihalomethanes causes increased formation of COHb. Combined exposure to CO and noise may potentiate noise-induced hearing loss.
Utgivare
Arbets- och miljömedicin, Göteborgs universitet
URL:
http://hdl.handle.net/2077/31966
Samlingar
  • Arbete och Hälsa
Fil(er)
gupea_2077_31966_1.pdf (1.181Mb)
Datum
2012
Författare
Stockman-Juvala, Helene; The Nordic Expert Group for Criteria Documentation; Arbetsmiljöverket
Nyckelord
auditory, carbon monoxide, carboxyhaemoglobin, cardiovascular,
Publikationstyp
report
ISBN
978-91-85971-41-1
ISSN
0346-7821
Serie/rapportnr.
Arbete och Hälsa; Vetenskaplig skriftserie
2012;46(7)
Språk
eng
Metadata
Visa fullständig post

DSpace software copyright © 2002-2016  DuraSpace
gup@ub.gu.se | Teknisk hjälp
Theme by 
Atmire NV
 

 

Visa

VisaSamlingarI datumordningFörfattareTitlarNyckelordDenna samlingI datumordningFörfattareTitlarNyckelord

Mitt konto

Logga inRegistrera dig

DSpace software copyright © 2002-2016  DuraSpace
gup@ub.gu.se | Teknisk hjälp
Theme by 
Atmire NV